N
Neuros Medical
Biotech & Life Sciences · Willoughby, United States · Founded 2008
Developing proprietary neurostimulation therapies for unmet needs to patients worldwide MoreLess
Neuros Medical, Inc., based in Cleveland, Ohio, is a neuromodulation company specializing in the development of proprietary therapies aimed at addressing unmet medical needs related to chronic pain. The company's patented platform technology, Electrical Nerve Block, focuses on treating various forms of chronic pain, including post-amputation pain, chronic post-surgical pain, and chronic migraines.
Neuros Medical primarily serves patients suffering from long-term pain conditions, which are often inadequately managed by existing treatments. The company operates within the medical technology market, specifically targeting the pain management segment.
Neuros Medical's business model revolves around the development and clinical testing of its proprietary Electrical Nerve Block technology. The company generates revenue through partnerships, licensing agreements, and potentially future sales of its medical devices once they receive regulatory approval.
The company's innovative approach aims to provide effective pain relief solutions, thereby improving the quality of life for patients worldwide.
Keywords: neuromodulation, chronic pain, Electrical Nerve Block, post-amputation pain, post-surgical pain, migraines, medical technology, pain management, proprietary therapies, clinical testing.
Company overview
Neuros Medical company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2008
- Headquarters
- Willoughby, United States
- Employees
- 54
- Open positions
- None listed
- Dealroom signal
- 90.2
Valuation & funding
Neuros Medical funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| DEBTDebt | Mar 2026 | $35M | — | Trinity Capital | ↗ |
| SERIES DOther financing | Jul 2025 | $56M | $224M | U.S. Venture Partners · Osage University Partners · Aperture Venture Partners · Amzak Health | ↗ |
| GROWTH EQUITY VCOther financing | Oct 2023 | $25M | — | Trinity Capital | ↗ |
| DEBTDebt | Nov 2022 | $8.2M | — | Undisclosed | ↗ |
| SERIES BOther financing | Jan 2021 | $39M | $154M | InCube Ventures · Aperture Venture Partners · Amzak Health Investors · Sectoral Asset Management | — |
| DEBTDebt | May 2020 | Undisclosed | — | ||
| EARLY VCOther financing | Oct 2019 | Undisclosed | — | ||
| SERIES AOther financing | Aug 2017 | Boston Scientific · Aperture Ventures Partners · RiverVest Venture Partners · Osage University Partners | — | ||
| SEEDOther financing | May 2016 | Undisclosed | — | ||
| SERIES BOther financing | Apr 2014 | Undisclosed | — |
Growth signals
Neuros Medical website traffic
Latest recorded traffic for Neuros Medical is 2.4K monthly website visits, up 20% over the last three months. Neuros Medical's team declined 1.8% over the past year.
Comparisons
Neuros Medical compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Neuros Medical's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Neuros Medical has talent and traffic
team presence
In the news
Latest news about Neuros Medical
Recent press, funding announcements, and product moves mentioning Neuros Medical — open to read from the original sources.
Market sentiment
What the market is saying about Neuros Medical
An AI-synthesized read of the highest-engagement posts about Neuros Medical on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Neuros Medical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.